These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2437020)

  • 1. Blocking enzyme linked immunosorbent assay additivity test for analysis of conformational or sequential recognition of monoclonal anti-luteinizing hormone releasing hormone (LHRH) antibodies.
    Singh V
    Indian J Exp Biol; 1986 Nov; 24(11):687-91. PubMed ID: 2437020
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on monoclonal antibodies to decapeptide luteinizing hormone releasing hormone (LHRH): structural requirement for recognition of LHRH by antibody.
    Singh V
    Indian J Exp Biol; 1986 Jan; 24(1):19-22. PubMed ID: 2426191
    [No Abstract]   [Full Text] [Related]  

  • 3. Influence of C-terminus carboxyl group of luteinizing hormone releasing hormone (LHRH) on recognition ability of anti-LHRH antibodies.
    Singh V
    Indian J Exp Biol; 1988 Nov; 26(11):905-6. PubMed ID: 3074048
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of immunogen modification of the gonadotropin releasing hormone antibody reactivity.
    Singh V
    Biochem Int; 1992 Aug; 27(4):579-89. PubMed ID: 1384494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-antibody competition technique for epitope analysis: studies on characteristics of epitope recognized by monoclonal anti-luteinizing hormone releasing hormone (LHRH) antibodies.
    Singh V
    Indian J Exp Biol; 1986 Apr; 24(4):209-12. PubMed ID: 2429924
    [No Abstract]   [Full Text] [Related]  

  • 6. Significance of C-terminus of decapeptide luteinizing hormone releasing hormone (LHRH) in antibody recognition.
    Singh V
    Indian J Exp Biol; 1986 Jan; 24(1):15-8. PubMed ID: 2426190
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of blocking ELISA additivity test and antibody-antibody competition technique for analysis of recognition ability of monoclonal anti-gonadotropin releasing hormone antibodies.
    Singh V
    Indian J Exp Biol; 1989 Jan; 27(1):5-9. PubMed ID: 2691398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunospecificity and affinity studies on anti-luteinizing hormone releasing hormone antibodies developed by azo-LHRH-TT and azo-LHRH-BSA conjugates.
    Singh V
    Biochem Int; 1992 Aug; 27(4):591-9. PubMed ID: 1417894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of monoclonal antibodies to Marburg virus nucleoprotein (NP) that can be used for NP-capture enzyme-linked immunosorbent assay.
    Saijo M; Niikura M; Maeda A; Sata T; Kurata T; Kurane I; Morikawa S
    J Med Virol; 2005 May; 76(1):111-8. PubMed ID: 15778962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy.
    Finstad CL; Wang CY; Kowalski J; Zhang M; Li ML; Li XM; Xia WG; Bosland MC; Murthy KK; Walfield AM; Koff WC; Zamb TJ
    Vaccine; 2004 Mar; 22(9-10):1300-13. PubMed ID: 15003660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantigenic epitopes of the B and D polypeptides of the U1 snRNP. Analysis of domains recognized by the Y12 monoclonal anti-Sm antibody and by patient sera.
    Hirakata M; Craft J; Hardin JA
    J Immunol; 1993 Apr; 150(8 Pt 1):3592-601. PubMed ID: 7682245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity and affinity characteristics of dog luteinizing hormone releasing hormone (LHRH) antibodies.
    Singh V
    Indian J Exp Biol; 1985 Dec; 23(12):673-5. PubMed ID: 3914452
    [No Abstract]   [Full Text] [Related]  

  • 13. Chaperone-like effect of monoclonal antibodies on refolding of heat-denatured carboxypeptidase A.
    Solomon B; Schwartz F
    J Mol Recognit; 1995; 8(1-2):72-6. PubMed ID: 7541231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human monoclonal antibody against ganglioside GD2: use in development of enzyme-linked immunosorbent assay for the monitoring of anti-GD2 in cancer patients.
    Tai T; Cahan LD; Paulson JC; Saxton RE; Irie RF
    J Natl Cancer Inst; 1984 Sep; 73(3):627-33. PubMed ID: 6206271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of the epitopes of proliferating cell nuclear antigen recognized by monoclonal antibodies.
    Roos G; Landberg G; Huff JP; Houghten R; Takasaki Y; Tan EM
    Lab Invest; 1993 Feb; 68(2):204-10. PubMed ID: 7680082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibodies against an identical short peptide sequence shared by two unrelated proteins.
    Schulze-Gahmen U; Wilson IA
    Pept Res; 1989; 2(5):322-31. PubMed ID: 2485209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibodies to luteinizing hormone-releasing hormone: production, characterization, and immunocytochemical application.
    Urbanski HF
    Biol Reprod; 1991 Apr; 44(4):681-6. PubMed ID: 2043738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of epitopes associated with hCG and the beta hCG carboxyl terminus by monoclonal antibodies produced against a synthetic peptide.
    Bidart JM; Ozturk M; Bellet DH; Jolivet M; Gras-Masse H; Troalen F; Bohuon CJ; Wands JR
    J Immunol; 1985 Jan; 134(1):457-64. PubMed ID: 2578049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative properties of polyclonal and monoclonal antibodies.
    Rodkey LS
    Methods Mol Biol; 1995; 51():139-50. PubMed ID: 7581692
    [No Abstract]   [Full Text] [Related]  

  • 20. Generation and epitope analysis of thyroid stimulating hormone-specific monoclonal antibodies for enzyme immunoassays.
    Chow SN; Chen KW; Su SL; Tung J; Lee CY
    Biotechnol Appl Biochem; 1988 Apr; 10(2):137-42. PubMed ID: 2454641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.